CTN CLINICAL COORDINATING CENTER TASK ORDER 9. POP 5/15/23 - 5/14/24.
CTN CLINICAL COORDINATING CENTER TASK ORDER 9. POP 5/15/23 - 5/14/24.
批准号:
10936242
负责人:
EVE JELSTROM
金额:
$598.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-05-15 至 2024-05-14
中文摘要
由NIDA资助的国家药物滥用治疗临床试验网络(CTN)于1999年首次建立,旨在弥合研究与实践之间的差距,以改善药物使用障碍的治疗。CTN是医疗和专业治疗提供者、治疗研究人员、参与的患者和NIDA可以合作开发、验证、改进和向患者提供新的物质使用障碍治疗方案的一种手段。这种伙伴关系使行为、药理学和综合行为/药理学治疗干预能够在严格的多地点临床试验中进行,以确定在广泛的社区治疗环境和不同患者群体中的治疗效果。这种伙伴关系还有助于将研究成果转移给医生、临床医生、提供者和患者,支持NIDA的最终目标,即加强为与物质使用障碍作斗争的个人提供科学治疗。隶属于CTN的临床研究人员提出临床研究的想法,如果被选中,研究将使用CTN平台进行开发和实施。临床试验网络(CTN)是一个由拨款资助的节点、一个签约临床协调中心、一个签约数据统计中心和一个签约后勤支持中心组成的协作框架。自2005年以来,Emmes公司一直签约为NIDA CTN的临床协调中心。
英文摘要
The National Drug Abuse Treatment Clinical Trials Network (CTN), funded by NIDA, was first established in 1999 to bridge the gap between research and practice to improve treatment of substance use disorders. The CTN is a means by which medical and specialty treatment providers, treatment researchers, participating patients, and NIDA can partner to cooperatively develop, validate, refine, and deliver new substance use disorder treatment options to patients. This partnership enables the conduct of behavioral, pharmacological, and integrated behavioral / pharmacological treatment interventions in rigorous, multi-site clinical trials to determine treatment effectiveness across a broad range of community-based treatment settings and diverse patient populations. This partnership also aids in the transfer of research results to physicians, clinicians, providers, and patients, supporting NIDA’s ultimate goal of enhancing the delivery of scientifically based treatments to individuals struggling with substance use disorder. Clinical investigators affiliated with the CTN propose ideas for clinical research studies and, if selected, the study is developed and conducted using the CTN platform. The Clinical Trials Network (CTN) is a collaborative framework of grant-funded nodes, a contracted Clinical Coordinating Center, a contracted Data and Statistics Center, and a contracted Logistics Support Center. Since 2005, the Emmes Company has been contracted as the Clinical Coordinating Center for the NIDA CTN.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FY23. CTN CLINICAL COORDINATING CENTER TASK ORDER 12. SEPTEMBER 15, 2023 TO SEPTEMBER 14, 2028.
-
批准号:10938769
-
项目类别:
-
资助金额:$79.69万
-
财政年份:2023
-
负责人:EVE JELSTROM
-
依托单位:
FY23. TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/24.
-
批准号:10938755
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2023
-
负责人:EVE JELSTROM
-
依托单位:
CTN CLINICAL COORDINATING CENTER TASK ORDER 8. POP 2/24/23 – 2/23/24
-
批准号:10936266
-
项目类别:
-
资助金额:$410.83万
-
财政年份:2023
-
负责人:EVE JELSTROM
-
依托单位:
FY23. TO 10 - CTN CLINICAL COORDINATING CENTER - CTN-0144. PERIOD OF PERFORMANCE: SEPTEMBER 7, 2023, TO DECEMBER 31, 2027
-
批准号:10938766
-
项目类别:
-
资助金额:$99.04万
-
财政年份:2023
-
负责人:EVE JELSTROM
-
依托单位:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
-
批准号:10617997
-
项目类别:
-
资助金额:$680.01万
-
财政年份:2022
-
负责人:EVE JELSTROM
-
依托单位:
MANAGEMENT OF UNHEALTHY OPIOID AND POLYSUBSTANCE USE AMONG PATIENTS IN PRIMARY CARE SETTINGS. FY22. POP 9/15/22 - 9/14/27.
-
批准号:10717060
-
项目类别:
-
资助金额:$129.99万
-
财政年份:2022
-
负责人:EVE JELSTROM
-
依托单位:
EXERCISE THE OPTION ITEM UNDER THE CLINICAL TRIALS NETWORK CLINICAL COORDINATING CENTER. JULY 6, 2022 - JULY 5, 2023. TASK ORDER 6
-
批准号:10720984
-
项目类别:
-
资助金额:$468.36万
-
财政年份:2022
-
负责人:EVE JELSTROM
-
依托单位:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
-
批准号:10538151
-
项目类别:
-
资助金额:$513.16万
-
财政年份:2021
-
负责人:EVE JELSTROM
-
依托单位:
海外基金